| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.074 | 0.8 |